Jia Shi Tang Co., Ltd.

Announcement on Receipt of Antitrust Review Non-Prohibition Decision and Progress of Equity Changes

Announcement of Resolutions from the Twenty-second Meeting of the Seventh Board of Directors

2026 Q1 Report

CITIC Securities Co., Ltd. Financial Advisor's Verification Opinion on the Detailed Report on Equity Changes of Jiasitang Pharmaceutical Co., Ltd. (Revised Version)

Detailed Report on Equity Changes of Jiashitang Pharmaceutical Co., Ltd. (Revised)

Brief Report on Equity Changes of Jiashitang Pharmaceutical Co., Ltd. (Revised)

Announcement on the Progress of Shareholders Signing the 'Transaction Price Payment Confirmation Agreement' and Changes in Equity

Jiashetang Pharmaceutical Co., Ltd. Board of Directors 2025 Annual Work Report

Announcement on Applying for a Comprehensive Credit Line from Banks in 2026

Goodwill Impairment Test Report

Assurance Report on the Special Explanation for Correction of Prior Period Accounting Errors

Financial Statements After Correction of Prior Period Accounting Errors

Announcement on Correction of Prior Period Accounting Errors and Retrospective Adjustment

2025 Annual Independent Director Performance Report (Zhang Haiyan)

2025 Annual Independent Director Performance Report (Liang Yu)

2025 Annual Independent Director Performance Report (Xiong Yan)

Notice Announcement on Holding the 2025 Annual Report Online Performance Briefing

Jiashetang Pharmaceutical Co., Ltd. 2025 Corporate Social Responsibility Report

2025 Annual Internal Control Audit Report

2025 Annual Internal Control Self-Assessment Report

Announcement on Provision for Goodwill Impairment

Announcement on Estimated Daily Related Party Transactions for 2026

Announcement on Providing Guarantees for Subsidiaries' Bank Credit Applications in 2026

Notice on Convening the 2025 Annual General Meeting of Shareholders

Resolutions Announcement of the 21st Meeting of the Seventh Board of Directors

Announcement on the 2025 Annual Profit Distribution Plan

Report of the Board of Directors' Audit Committee on the Assessment of the Accounting Firm's Performance in 2025 and the Fulfillment of Supervision Responsibilities

Special Report on Related Party Fund Transactions

"Special Opinion of the Board of Directors of Jiashetang Pharmaceutical Co., Ltd. on the Self

"2025 Annual Audit Report",

"Announcement on Convening the 2025 Annual Performance Briefing",